Putting pacemakers and defibrillators into an antibacterial, absorbable envelope protects patients, study shows.
During assessment of a hip injury, patient Debbie Davis was found to have a failing aortic valve.
UW Medicine cardiologists have developed a tool to predict which heart-failure patients stand to gain most, and least, from an implanted defibrillator.
In April, Ed Ward, 74, became the first patient on the West Coast to receive a test device implanted in his heart to reduce the symptoms of heart failure. Dr.
A UW Medicine surgeon performed a landmark procedure this week, implanting tiny, steroid-releasing devices in a patient’s sinuses to reduce the recurrence of nasal polyps. It was the device’s first West Coast deployment and the third such U.S.
Patients with chronic kidney and heart conditions have little benefit from devices that curb irregular heartbeats, researchers find.
UW Medicine’s Regional Heart Center is enrolling patients in a clinical trial that may be the final threshold to a new standard of care for aortic-valve replacement.
In the 1980s, cardiologists recognized that patients with heart failure – a poor quality of blood-pumping that can persist for years – were also more likely to die suddenly of cardiac arrest.
An international team led by researchers at the Center for Sensorimotor Neural Engineering at the University of Washington is one of three finalists in a race to produce an implantable wireless device that